28.11.2018 • News

Vantage to Acquire Germany’s Leuna-Tenside

Vantage to Acquire Germany’s Leuna-Tenside (c) AVAVA/Shutterstock
Vantage to Acquire Germany’s Leuna-Tenside (c) AVAVA/Shutterstock

US-based Vantage Specialty Chemicals has agreed to buy German surfactants specialist Leuna-Tenside from two equity investors.

Germany’s VR Equitypartner and Luxembourg-based BIP Investment Partners acquired a majority interest in Leuna-Tenside in 2015. The company was founded in 1995 as part of the management buyout of a business division of the former Leuna-Werke.

Christian Futterlieb, managing director of VR Equitypartner, said that, thanks to joint efforts with management, Leuna-Tenside is now well positioned in the market. He commented: “The company enjoys an outstanding competitive edge thanks to its ability to pursue customized surfactant chemistry within a dynamic niche.”

Leuna-Tenside’s managing director, Steve Döring, added that Vantage’s interest recognizesthe tremendous opportunities available for the business, including enhanced access to international markets, especially the US, and numerous cross-selling opportunities.

Financial terms have not been disclosed but Moody’s Investors Service said Vantage will add $88 million to its existing loans to finance the acquisition and pay for transaction fees and expenses.

The purchase remains subject to approval from regulatory authorities. Vantage did not say when it expects the deal to close.

 Vantage, which was itself repurchased by US private equity group H.I.G. Capital in October 2017, completed another acquisition in September 2018, notably that of Amarna, a leading manufacturer of water-based release agents, which are used in a variety of food applications. The company is based at Delta, Colorado, USA.

Keval Patel, managing director at H.I.G., said the Amarna investment continues a strategy of acquiring green, unique and complementary technologies in attractive, high-growth end markets.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read